VKTX
USDViking Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$36.740
Hoch
$38.000
Tief
$34.615
Volumen
3.77M
Unternehmensfundamentaldaten
Marktkapitalisierung
3.9B
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
6.60M
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Canaccord Genuity Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $106
Canaccord Genuity analyst Edward Nash initiates coverage on Viking Therapeutics with a Buy rating and announces Price Target of $106.
JP Morgan Maintains Overweight on Viking Therapeutics, Lowers Price Target to $75
JP Morgan analyst Hardik Parikh maintains Viking Therapeutics with a Overweight and lowers the price target from $80 to $75.
Morgan Stanley Maintains Overweight on Viking Therapeutics, Raises Price Target to $102
Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics with a Overweight and raises the price target from $98 to $102.
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.